Drug Shortage Report for MYLAN-DIVALPROEX
Report ID | 78971 |
Drug Identification Number | 02458934 |
Brand name | MYLAN-DIVALPROEX |
Common or Proper name | MYLAN-DIVALPROEX |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VALPROIC ACID |
Strength(s) | 250MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 100 BT, 500 BT |
ATC code | N03AG |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-04-17 |
Actual start date | |
Estimated end date | 2019-04-22 |
Actual end date | 2019-03-28 |
Shortage status | Avoided shortage |
Updated date | 2019-03-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-03-28 | French | Compare |
v3 | 2019-03-28 | English | Compare |
v2 | 2019-03-20 | French | Compare |
v1 | 2019-03-20 | English | Compare |
Showing 1 to 4 of 4